Most significant genes involved cases spanning more than one histologic type, and a few key genes, including EGFR and MYCN were significant only in the pan-cancer analysis and not associated with any individual tumor type, which highlights the utility of our pan-cancer approach. This evidence concerns the gene EGFR and neoplasm.